Evidence map›Paper›PMID 35573013›Full record

ArticleFrontiers in medicine2022

Veno-Venous Extracorporeal Membrane Oxygenation in Minipigs as a Robust Tool to Model Acute Kidney Injury: Technical Notes and Characteristics.

Antal Szabó-Biczók, Gabriella Varga, Zoltán Varga, Gábor Bari, Gyöngyvér Vigyikán, Ámos Gajda, Noémi Vida, Ádám Hodoniczki, Attila Rutai, László Juhász and 5 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Antal Szabó-BiczókDivision of Cardiac Surgery, Second Department of Internal Medicine and Cardiology Center, University of Szeged, Szeged, Hungary.
Gabriella VargaInstitute of Surgical Research, University of Szeged, Szeged, Hungary.
Zoltán VargaInstitute of Surgical Research, University of Szeged, Szeged, Hungary.
Gábor BariDivision of Cardiac Surgery, Second Department of Internal Medicine and Cardiology Center, University of Szeged, Szeged, Hungary.
Gyöngyvér VigyikánInstitute of Surgical Research, University of Szeged, Szeged, Hungary.
Ámos GajdaInstitute of Surgical Research, University of Szeged, Szeged, Hungary.
Noémi VidaInstitute of Surgical Research, University of Szeged, Szeged, Hungary.
Ádám HodoniczkiInstitute of Surgical Research, University of Szeged, Szeged, Hungary.
Attila RutaiInstitute of Surgical Research, University of Szeged, Szeged, Hungary.
László JuhászInstitute of Surgical Research, University of Szeged, Szeged, Hungary.
Anna NászaiInstitute of Surgical Research, University of Szeged, Szeged, Hungary.
Máté GyöngyösiInstitute of Surgical Research, University of Szeged, Szeged, Hungary.
Sándor Turkevi-NagyDepartment of Pathology, University of Szeged, Szeged, Hungary.
Dániel ÉrcesInstitute of Surgical Research, University of Szeged, Szeged, Hungary.
Mihály BorosInstitute of Surgical Research, University of Szeged, Szeged, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Veno-venous extracorporeal membrane oxygenation (vv-ECMO) can save lives in severe respiratory distress, but this innovative approach has serious side-effects and is accompanied by higher rates of iatrogenic morbidity. Our aims were, first, to establish a large animal model of vv-ECMO to study the pathomechanism of complications within a clinically relevant time frame and, second, to investigate renal reactions to increase the likelihood of identifying novel targets and to improve clinical outcomes of vv-ECMO-induced acute kidney injury (AKI). Methods: Anesthetized Vietnamese miniature pigs were used. After cannulation of the right jugular and femoral veins, vv-ECMO was started and maintained for 24 hrs. In Group 1 ( Results: During the post-ECMO period, RAF dropped (96.3 ± 21 vs. 223.6 ± 32 ml/min) and, similarly, hour diuresis was significantly lower as compared to the control group (3.25 ± 0.4 ml/h/kg vs. 4.83 ± 0.6 ml/h/kg). Renal histology demonstrated significant structural damage characteristic of ischemic injury in the tubular system. In the vv-ECMO group NGAL levels, rose significantly in both urine (4.24 ± 0.25 vs. 2.57 ± 0.26 ng/ml) and plasma samples (4.67 ± 0.1 vs. 3.22 ± 0.2 ng/ml), while tissue XOR (5.88 ± 0.8 vs. 2.57 ± 0.2 pmol/min/mg protein) and MPO (11.93 ± 2.5 vs. 4.34 ± 0.6 mU/mg protein) activity was elevated. HRR showed renal mitochondrial dysfunction, including a significant drop in complex-I-dependent oxidative capacity (174.93 ± 12.7 vs. 249 ± 30.07 pmol/s/ml). Conclusion: Significantly decreased renal function with signs of structural damage and impaired mitochondrial function developed in the vv-ECMO group. The vv-ECMO-induced acute renal impairment in this 30-hr research protocol provides a good basis to study the pathomechanism, biomarker combinations or possible therapeutic possibilities for AKI.

Indexed as

extracorporeal membrane oxygenationinflammationischemiakidney injurymitochondrial functionrenal artery flow

Identifiers

PMID35573013
PMCPMC9097577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.